CHRO logo

Channel Therapeutics Corporation (CHRO)

Profile

Full Name

Channel Therapeutics Corporation

Ticker

NYSEAmerican: CHRO

Exchange

NYSE American

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

February 16, 2024

Indexes

Not included

Website

http://channeltherapeutics.com

Employees

4

Key Details

Price

$19.88(-23.39%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $19.88
    CHRO price is $19.88

    30-Day Relative Volume

    2.48
    CHRO 30-day relative volume is 2.48

    Price Performance

    Price Most recent change

    -23.39%
    CHRO price was down -23.39% on Jul 8, 2025

    Price YTD change

    +210.14%
    CHRO price is up +210.14% since January 1st

    Price 1-year change

    +79.91%
    CHRO price is up +79.91% year-on-year

    Price 3-year change

    -
    CHRO price 3-year change is unknown

    Price Range

    Price All-time high

    $60.00
    CHRO price is currently -66.87% below its historical high of $60.00

    Price 3-year low

    $4.50
    CHRO price is currently +341.78% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $11.47M
    CHRO market capitalization is $11.47 million

    Market cap 3-year change

    -
    CHRO market capitalization 3-year change is unknown

    Market cap All-time high

    $27.69M
    CHRO market capitalization is currently -58.58% below its historical high of $27.69 million

    Market cap sector rank

    18.55%
    CHRO market capitalization is higher than 18.55% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    0%
    CHRO {parameterFullLabel} has remained unchanged year-on-year

    Shares Outstanding 3-Year Change

    -
    CHRO shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.23
    CHRO beta is 1.23

    200-day SMA

    $11.79
    CHRO price is currently +68.62% above its 200-day simple moving average

    50-day SMA

    $12.07
    CHRO price is currently +64.75% above its 50-day simple moving average

    RSI

    63.56
    CHRO 14-day relative strength index is 63.56

    Volume

    2.48
    CHRO 30-day relative volume is 2.48

    ATR

    $5.71
    CHRO average true range is $5.71

    10-day Historical Volatility

    354.28%
    CHRO 10-day historical volatility is 354.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    CHRO annual revenue is $0.00

    Revenue Analysts estimate

    -
    CHRO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    CHRO {parameterFullLabel} has remained unchanged year-on-year

    Revenue Sector rank

    1.14%
    CHRO annual revenue is higher than 1.14% of companies in Healthcare sector

    EPS

    EPS

    -
    CHRO annual earnings per share value is unknown

    EPS Analysts estimate

    -$1.10
    CHRO annual earnings per share is currently equal to the consensus analysts' forecast

    EPS 1-year change

    -
    CHRO annual earnings per share 1-year change is unknown

    EPS Sector rank

    -
    CHRO annual earnings per share is unknown

    Profit

    Gross profit

    -
    CHRO annual gross profit value is unknown

    Gross margin

    -
    CHRO annual gross profit margin value is unknown

    Operating profit

    -$7.57M
    CHRO annual operating income is -$7.57 million

    Operating margin

    -
    CHRO annual operating profit margin value is unknown

    Net income

    -$7.96M
    CHRO annual net profit is -$7.96 million

    Net margin

    -
    CHRO annual net profit margin value is unknown

    Expenses

    Total expenses

    $7.57M
    CHRO annual total expenses is $7.57 million

    Operating expenses

    $7.57M
    CHRO annual total operating expenses is $7.57 million

    Cost of goods sold

    -
    CHRO annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $6.39M
    CHRO annual SGA is $6.39 million

    Depreciation and amortization

    -
    CHRO annual depreciation & amortization value is unknown

    Interest expense

    $786.39K
    CHRO annual interest expense is $786.39 thousand

    Income tax

    $0.00
    CHRO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$7.17M
    CHRO annual earnings before interest & taxes is -$7.17 million

    EBITDA

    -$7.53M
    CHRO annual EBITDA is -$7.53 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $1.37M
    CHRO annual total assets is $1.37 million

    Non current assets

    $0.00
    CHRO annual long term assets is $0.00

    Current assets

    $1.37M
    CHRO annual total current assets is $1.37 million

    Cash and cash equivalents

    $513.44K
    CHRO annual cash & cash equivalents is $513.44 thousand

    Accounts receivable

    -
    CHRO annual accounts receivable value is unknown

    Inventory

    -
    CHRO annual inventory value is unknown

    Liabilities

    Total liabilities

    $4.08M
    CHRO annual total liabilities is $4.08 million

    Long term liabilities

    $0.00
    CHRO annual total long term liabilities is $0.00

    Current liabilities

    $4.08M
    CHRO annual total current liabilities is $4.08 million

    Accounts payable

    $1.90M
    CHRO annual accounts payable is $1.90 million

    Debt

    Total debt

    $2.19M
    CHRO annual total debt is $2.19 million

    Total debt 1-year change

    +72.31%
    CHRO annual total debt is up +72.31% year-on-year

    Long term debt

    -
    CHRO annual long term debt value is unknown

    Short term debt

    $2.19M
    CHRO annual short term debt is $2.19 million

    Equity & Capital

    Shareholders equity

    -$2.71M
    CHRO annual stockholders equity is -$2.71 million

    Book value

    -$2.71M
    CHRO annual book value is -$2.71 million

    Retained earnings

    -$21.47M
    CHRO annual retained earnings is -$21.47 million

    Working capital

    -$2.71M
    CHRO annual working capital is -$2.71 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$5.79M
    CHRO annual cash flow from operations is -$5.79 million

    Cash from operations 1-year change

    -490.45%
    CHRO annual cash flow from operations is down -490.45% year-on-year

    Cash from investing

    -
    CHRO annual cash flow from investing activities value is unknown

    Cash from investing 1-year change

    -
    CHRO annual cash flow from investing activities 1-year change is unknown

    Cash from financing

    $6.21M
    CHRO annual cash flow from financing activities is $6.21 million

    Cash from financing 1-year change

    +507.38%
    CHRO annual cash flow from financing activities is up +507.38% year-on-year

    CAPEX

    CAPEX

    -
    CHRO annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    CHRO annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$5.79M
    CHRO annual free cash flow is -$5.79 million

    Free cash flow 1-year change

    -490.45%
    CHRO annual free cash flow is down -490.45% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    CHRO annual gross profit margin value is unknown

    Operating margin

    -
    CHRO annual operating profit margin value is unknown

    Net margin

    -
    CHRO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -581.05%
    CHRO annual return on assets is -581.05%

    ROE

    293.12%
    CHRO annual return on equity is 293.12%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CHRO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CHRO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.73
    CHRO price to book ratio is -2.73

    PB ratio Sector rank

    6.85%
    CHRO price to book ratio is higher than 6.85% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    CHRO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    CHRO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $13.84M
    CHRO enterprise value is $13.84 million

    Enterprise value Sector rank

    24.19%
    CHRO enterprise value is higher than 24.19% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.86
    CHRO EV/EBITDA is -1.86

    EV/EBITDA Sector rank

    39.65%
    CHRO EV/EBITDA is higher than 39.65% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.34
    CHRO annual current ratio is 0.34

    Quick ratio

    -
    CHRO annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.81
    CHRO annual debt to equity ratio is -0.81

    Interest coverage ratio

    -9.12
    CHRO annual interest coverage ratio is -9.12

    Risk & Stability

    Piotroski F-Score

    -
    CHRO piotroski f-score value is unknown

    Altman Z-Score

    -39.93
    CHRO altman z-score is -39.93

    Analyst ratings

    Recent major analysts updates

    Jun 18, 24 Alliance Global Partners
    Buy

    Institutional Ownership

    Screeners with CHRO included

    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    Healthcare sector
    All stocks
    Best performing stocks last 12 months
    Biotechnology industry
    Best performing stocks YTD
    • What is the ticker symbol for Channel Therapeutics Corporation?
    • Does Channel Therapeutics Corporation pay dividends?
    • What sector is Channel Therapeutics Corporation in?
    • What industry is Channel Therapeutics Corporation in?
    • What country is Channel Therapeutics Corporation based in?
    • When did Channel Therapeutics Corporation go public?
    • Is Channel Therapeutics Corporation in the S&P 500?
    • Is Channel Therapeutics Corporation in the NASDAQ 100?
    • Is Channel Therapeutics Corporation in the Dow Jones?
    • When does Channel Therapeutics Corporation report earnings?

    What is the ticker symbol for Channel Therapeutics Corporation?

    The ticker symbol for Channel Therapeutics Corporation is NYSEAmerican:CHRO

    Does Channel Therapeutics Corporation pay dividends?

    No, Channel Therapeutics Corporation does not pay dividends

    What sector is Channel Therapeutics Corporation in?

    Channel Therapeutics Corporation is in the Healthcare sector

    What industry is Channel Therapeutics Corporation in?

    Channel Therapeutics Corporation is in the Biotechnology industry

    What country is Channel Therapeutics Corporation based in?

    Channel Therapeutics Corporation is headquartered in United States

    When did Channel Therapeutics Corporation go public?

    Channel Therapeutics Corporation's initial public offering (IPO) was on February 16, 2024

    Is Channel Therapeutics Corporation in the S&P 500?

    No, Channel Therapeutics Corporation is not included in the S&P 500 index

    Is Channel Therapeutics Corporation in the NASDAQ 100?

    No, Channel Therapeutics Corporation is not included in the NASDAQ 100 index

    Is Channel Therapeutics Corporation in the Dow Jones?

    No, Channel Therapeutics Corporation is not included in the Dow Jones index

    When does Channel Therapeutics Corporation report earnings?

    The date for Channel Therapeutics Corporation's next earnings report has not been announced yet
    On this page